全文获取类型
收费全文 | 1232003篇 |
免费 | 82439篇 |
国内免费 | 1770篇 |
专业分类
耳鼻咽喉 | 17110篇 |
儿科学 | 39765篇 |
妇产科学 | 31953篇 |
基础医学 | 174762篇 |
口腔科学 | 36780篇 |
临床医学 | 106512篇 |
内科学 | 239138篇 |
皮肤病学 | 28465篇 |
神经病学 | 94699篇 |
特种医学 | 47815篇 |
外国民族医学 | 227篇 |
外科学 | 182645篇 |
综合类 | 22959篇 |
现状与发展 | 2篇 |
一般理论 | 322篇 |
预防医学 | 91480篇 |
眼科学 | 27528篇 |
药学 | 95698篇 |
7篇 | |
中国医学 | 3454篇 |
肿瘤学 | 74891篇 |
出版年
2021年 | 10958篇 |
2019年 | 10938篇 |
2018年 | 15747篇 |
2017年 | 12227篇 |
2016年 | 13218篇 |
2015年 | 14929篇 |
2014年 | 20310篇 |
2013年 | 28610篇 |
2012年 | 40471篇 |
2011年 | 42785篇 |
2010年 | 24290篇 |
2009年 | 22563篇 |
2008年 | 38046篇 |
2007年 | 40763篇 |
2006年 | 40719篇 |
2005年 | 39291篇 |
2004年 | 37427篇 |
2003年 | 35628篇 |
2002年 | 32866篇 |
2001年 | 64480篇 |
2000年 | 65888篇 |
1999年 | 54859篇 |
1998年 | 13865篇 |
1997年 | 12181篇 |
1996年 | 12205篇 |
1995年 | 11323篇 |
1994年 | 10332篇 |
1993年 | 9765篇 |
1992年 | 40199篇 |
1991年 | 38600篇 |
1990年 | 37887篇 |
1989年 | 36395篇 |
1988年 | 32810篇 |
1987年 | 31781篇 |
1986年 | 29904篇 |
1985年 | 28048篇 |
1984年 | 20349篇 |
1983年 | 17050篇 |
1982年 | 9357篇 |
1979年 | 17887篇 |
1978年 | 11970篇 |
1977年 | 10665篇 |
1976年 | 9208篇 |
1975年 | 10574篇 |
1974年 | 12163篇 |
1973年 | 11776篇 |
1972年 | 11173篇 |
1971年 | 10484篇 |
1970年 | 9679篇 |
1969年 | 9366篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Aneurisma de aorta abdominal infrarrenal en asociación con riñón en herradura: aportación de un caso
Nerea Senarriaga Ruiz de la Illa Reyes Vega Manrique Isabel Lacasa Viscasillas Iñaki Iriarte Soldevilla Miguel Unda Urzaiz 《Actas urologicas espa?olas》2009,33(10):1141-1144
We review the association between surgically resolvable aortic disease and horseshoe kidney with a discussion of diagnostic problems and therapeutic options.Male patient 81 years of age with horseshoe kidney and an abdominal aortic aneurysm that was discovered by chance in an abdominal ultrasound during a check-up for his prostate condition.A retroperitoneal approach was used in order to resect the aneurysm and perform an aorto-aortic bypass with no complications occurring. Two years after the diagnosis, the patient is still asymptomatic from a vascular point of view.The co-presence of horseshoe kidney and aortic disease needing surgical correction is infrequent, but it significantly increases the technical complexity of aortic reconstruction. A literature review is included. 相似文献
992.
993.
994.
995.
996.
G Gaitanis K Nomikos E Vava EC Alexopoulos ID Bassukas 《Journal of the European Academy of Dermatology and Venereology》2009,23(12):1427-1431
Background/aim Theoretical considerations support the combination of cryosurgery and topical imiquimod to treat basal cell carcinomas (BCC). The aim of the present study was to test the feasibility and efficacy of 'cryosurgery during continued imiquimod application' ('immunocryosurgery') to treat 'high-risk-for-recurrence' BCCs.
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N2 cryosurgery (spray, two cycles, 10–20 s) and imiquimod was continued for additional 2–12 weeks (median, 4). The outcome after at least 18 months of follow-up (18–24 months) is currently reported.
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献
Methods Thirteen patients with 21 biopsy-proven tumours (4 of 21 relapses after prior surgery) were included. After 2–5 weeks (median, 3) of daily 5% imiquimod cream application, the tumours were treated by liquid N
Results Nineteen of 21 tumours responded promptly to immunocryosurgery; two tumours required additional treatment cycles to clear. Thus, the clinical clearance rate was 100%. Only 1 of 21(5%) tumour relapsed after at least 18 months of follow-up (cumulative efficacy: 95%).
Conclusions 'Immunocryosurgery' is a promising non-surgical combination modality to treat 'high-risk-for-recurrence BCCs'. Initial evidence is suggestive of an at least additive effect of the two combined modalities. Further studies comparing immunocryosurgery directly with cryosurgery and imiquimod monotherapies will confirm the reported results. 相似文献
997.
998.
999.
1000.